Economic Burden of Malignant Tumors - Yichang City, Hubei Province, China, 2019

Xiaojuan Long; Fangfang Lu; Xianglong Xiang; Jiajuan Yang; Chengzhong Xu; Pei Zhang; Shicheng Yu; Qiqi Wang; Chi Hu

doi:10.46234/ccdcw2022.037

Economic Burden of Malignant Tumors - Yichang City, Hubei Province, China, 2019

China CDC Wkly. 2022 Apr 15;4(15):312-316. doi: 10.46234/ccdcw2022.037.

Authors

Xiaojuan Long¹, Fangfang Lu², Xianglong Xiang¹, Jiajuan Yang², Chengzhong Xu², Pei Zhang², Shicheng Yu¹, Qiqi Wang¹, Chi Hu²

Affiliations

¹ Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China.
² Yichang Center for Disease Control and Prevention, Yichang City, Hubei Province, China.

Abstract

What is already known about this topic?: Malignant tumors are common chronic non-communicable disease and have caused serious health hazards to residents and heavy economic burden of disease to the society.

What is added by this report?: This is the first report on the economic burden of multiple types of malignant tumors in Yichang City. In 2019, the direct medical burden of lung cancer in Yichang was the highest, reaching 561.67 million CNY, and the indirect economic burden of lung cancer in Yichang was higher than that of other malignant tumors, costing 326.49 million CNY.

What are the implications for public health practice?: The results can provide evidence for the formulation of local cancer prevention and control strategies and public health decision-making.

Keywords: Burden of disease; Economic Burden; Malignant Tumors.

Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022.

Grants and funding

Supported by National Key Research and Development Program “Applied Study on the Data-driven Prevention and Control Strategies of the Major Chronic Diseases” (2018YFC1315305)